A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 2,344 shares of ABBV stock, worth $377,946. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,344
Previous 2,328 0.69%
Holding current value
$377,946
Previous $361 Million 18.31%
% of portfolio
0.24%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $2,557 - $2,913
16 Added 0.69%
2,344 $427 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $320,332 - $360,770
2,328 New
2,328 $361 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $285B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Twin Peaks Wealth Advisors, LLC Portfolio

Follow Twin Peaks Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Peaks Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Peaks Wealth Advisors, LLC with notifications on news.